While the dollar amount is small relative to market cap, the participation of the CEO and two other top executives in coordinated selling may signal reduced conviction at a leadership level. Traders should monitor for absence of offsetting buy signals and watch for any upcoming filings or guidance that could explain the timing.
Price Chart
Executive Summary
Three senior executives at Vertex Pharmaceuticals — including the CEO and two EVPs — sold shares in a coordinated 7-day window, generating over $1.75 million in proceeds. All transactions were open-market sales at prevailing prices, with no grants, awards, or tax-related dispositions involved.
Key Financial Metrics
Key Facts
- CEO Reshma Kewalramani sold 400 shares for $191,900 in an open-market transaction.
- EVP Carmen Bozic sold 2,329 shares for $1.12M, the largest individual sale in the cluster.
- EVP Joy Liu sold 892 shares for $442,396, completing the cluster of C-suite dispositions.
- Total value of open-market sales: $1.753M across three insiders, all within seven days.
- Sales represent approximately 0.00145% of Vertex's $120.5B market cap — small in relative terms but notable due to concentration among top executives.
Financial Impact
$1.753 million in open-market share sales by C-suite executives
Risk Factors
- Perception of insider pessimism, especially given the rarity of CEO sales at this level.
- Potential for negative market reaction if no clear rationale (e.g., pre-arranged 10b5-1 plan) is disclosed.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (3 trades, 7d window) | cluster-VRTX-1772659472274 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 7, 2026 12w ago | 8-K | $522.25 $522.81 | ▲ +0.11% | ▼ −1.89% | $506.74 (−2.97%) |
Jul 7, 2026 12w ago | Insider Cluster | $522.25 $522.81 | ▲ +0.11% | ▼ −1.89% | $506.74 (−2.97%) |
Jul 6, 2026 12w ago | Insider Cluster | $529.59 $526.73 | ▼ −0.54% | ▼ −2.26% | $506.74 (−4.31%) |
Jun 3, 2026 17w ago | Insider Cluster | $441.47 $541.69 | ▲ +22.70% | ▲ +21.08% | $506.74 (+14.79%) |
May 19, 2026 19w ago | Insider Cluster | $430.05 $505.75 | ▲ +17.60% | ▲ +12.87% | $506.74 (+17.83%) |
Mar 11, 2026 29w ago | Insider Cluster | $491.96 $428.34 | ▼ −12.93% | ▼ −24.45% | $506.74 (+3.01%) |
Feb 25, 2026 31w ago | Insider Cluster | $482.92 $430.44 | ▼ −10.87% | ▼ −17.82% | $506.74 (+4.93%) |
Feb 25, 2026 31w ago | Insider Cluster | $482.92 $430.44 | ▲ +10.87% | ▲ +17.82% | $506.74 (−4.93%) |
Feb 25, 2026 31w ago | Insider Cluster | $482.92 $430.44 | ▼ −10.87% | ▼ −17.82% | $506.74 (+4.93%) |
Feb 25, 2026 31w ago | Insider Cluster | $482.92 $430.44 | ▼ −10.87% | ▼ −17.82% | $506.74 (+4.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access